|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Molina JR, Adjei AA and Jett JR: Advances
in chemotherapy of non-small cell lung cancer. Chest.
130:1211–1219. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kadota K, Huang CL, Liu D, Nakashima N,
Yokomise H, Ueno M and Haba R: The clinical significance of the
tumor cell D2-40 immunoreactivity in non-small cell lung cancer.
Lung Cancer. 70:88–93. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gao Y, Liu Z, Gao F and Meng XY: High
density of peritumoral lymphatic vessels is a potential prognostic
marker of endometrial carcinoma: A clinical immunohistochemical
method study. BMC Cancer. 10:1312010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen W, Li Y, Liao Z, Lin G, Cai G, Lin K,
Zhan Q and Chen C: Active lymphangiogenesis is a major risk factor
for anastomotic leakage following sphincter-sparing resection of
rectal cancer. J Surg Oncol. 104:493–498. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen D, Zheng J, Li H, Wang Q and Jiao X:
Computer-assisted morphometric analysis of lymphatic vessel changes
in hamster tongue carcinogenesis. J Oral Pathol Med. 39:518–524.
2010.PubMed/NCBI
|
|
7
|
Sasahira T, Kirita T, Kurihara M, Yamamoto
K, Bhawal UK, Bosserhoff AK and Kuniyasu H: MIA-dependent
angiogenesis and lymphangiogenesis are closely associated with
progression, nodal metastasis and poor prognosis in tongue squamous
cell carcinoma. Eur J Cancer. 46:2285–2294. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vittet D and Feige JJ: Lymphangiogenesis
and tumor progression]. Bull Cancer. 94:881–886. 2007.In French.
PubMed/NCBI
|
|
9
|
Sun JG, Wang Y, Chen ZT, Zhuo WL, Zhu B,
Liao RX and Zhang SX: Detection of lymphangiogenesis in non-small
cell lung cancer and its prognostic value. J Exp Clin Cancer Res.
28:212009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Heinzelbecker J, Kempf KM, Kurz K,
Steidler A, Weiss C, Jackson DG, Bolenz C, Haecker A and Trojan L:
Lymph vessel density in seminomatous testicular cancer assessed
with the specific lymphatic endothelium cell markers D2-40 and
LYVE-1: Correlation with pathologic parameters and clinical
outcome. Urol Oncol. 31:1386–1394. 2013. View Article : Google Scholar
|
|
11
|
Feng Y, Wang W, Hu J, Ma J, Zhang Y and
Zhang J: Expression of VEGF-C and VEGF-D as significant markers for
assessment of lymphangiogenesis and lymph node metastasis in
non-small cell lung cancer. Anat Rec. 293:802–812. 2010. View Article : Google Scholar
|
|
12
|
Tamura K, Matsushita M, Endo A, Kutsukake
M and Kogo H: Effect of insulin-like growth factor-binding protein
7 on steroidogenesis in granulosa cells derived from equine
chorionic gonadotropin-primed immature rat ovaries. Biol Reprod.
77:485–491. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ruan W, Xu E, Xu F, Ma Y, Deng H, Huang Q,
Lv B, Hu H, Lin J, Cui J, et al: IGFBP7 plays a potential tumor
suppressor role in colorectal carcinogenesis. Cancer Biol Ther.
6:354–359. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wajapeyee N, Serra RW, Zhu X, Mahalingam M
and Green MR: Oncogenic BRAF induces senescence and apoptosis
through pathways mediated by the secreted protein IGFBP7. Cell.
132:363–374. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pen A, Moreno MJ, Durocher Y, Deb-Rinker P
and Stanimirovic DB: Glioblastoma-secreted factors induce IGFBP7
and angiogenesis by modulating Smad-2-dependent TGF-beta signaling.
Oncogene. 27:6834–6844. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang YJ, Niu J, Liu Z, Wang LE, Sturgis
EM and Wei Q: The functional IGFBP7 promoter -418G>A
polymorphism and risk of head and neck cancer. Mutat Res.
702:32–39. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu LB, Liu C, Gao GQ, Yu XH, Zhang R and
Wang J: Nerve growth factor-beta expression is associated with
lymph node metastasis and nerve infiltration in human hilar
cholangiocarcinoma. World J Surg. 34:1039–1045. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang J, Guo Y, Zhang BC, Chen ZT and Gao
JF: Induction of apoptosis and inhibition of cell migration and
tube-like formation by dihydroartemisinin in murine lymphatic
endothelial cells. Pharmacology. 80:207–218. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang B, Wang J, Gao J, Guo Y, Chen X,
Wang B, Gao J, Rao Z and Chen Z: Alternatively activated RAW264.7
macrophages enhance tumor lymphangiogenesis in mouse lung
adenocarcinoma. J Cell Biochem. 107:134–143. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen Z, Wang T, Luo H, Lai Y, Yang X, Li
F, Lei Y, Su C, Zhang X, Lahn BT, et al: Expression of nestin in
lymph node metastasis and lymphangiogenesis in non-small cell lung
cancer patients. Hum Pathol. 41:737–744. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Saban MR, Towner R, Smith N, Abbott A,
Neeman M, Davis CA, Simpson C, Maier J, Mémet S, Wu XR, et al:
Lymphatic vessel density and function in experimental bladder
cancer. BMC Cancer. 7:2192007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sleeman JP and Thiele W: Tumor metastasis
and the lymphatic vasculature. Int J Cancer. 125:2747–2756. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang J, Li K, Wang B and Bi J: Lymphatic
microvessel density as a prognostic factor in non-small cell lung
carcinoma: A meta-analysis of the literature. Mol Biol Rep.
39:5331–5338. 2012. View Article : Google Scholar
|
|
24
|
Achen MG and Stacker SA: Molecular control
of lymphatic metastasis. Ann NY Acad Sci. 1131:225–234. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bièche I, Lerebours F, Tozlu S, Espie M,
Marty M and Lidereau R: Molecular profiling of inflammatory breast
cancer: Identification of a poor-prognosis gene expression
signature. Clin Cancer Res. 10:6789–6795. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang Y, Zhang D, Zheng W, Luo J, Bai Y and
Lu Z: Multiple gene methylation of nonsmall cell lung cancers
evaluated with 3-dimensional microarray. Cancer. 112:1325–1336.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ramsauer M and D'Amore PA: Contextual role
for angiopoietins and TGFbeta1 in blood vessel stabilization. J
Cell Sci. 120:1810–1817. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shersher DD, Vercillo MS, Fhied C, Basu S,
Rouhi O, Mahon B, Coon JS, Warren WH, Faber LP, Hong E, et al:
Biomarkers of the insulin-like growth factor pathway predict
progression and outcome in lung cancer. Ann Thorac Surg.
92:1805–1811. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nancarrow DJ, Clouston AD, Smithers BM,
Gotley DC, Drew PA, Watson DI, Tyagi S, Hayward NK and Whiteman DC;
Australian Cancer Study; Study of Digestive Health: Whole genome
expression array profiling highlights differences in mucosal
defense genes in Barrett's esophagus and esophageal adenocarcinoma.
PLoS One. 6:e225132011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jacob K, Quang-Khuong DA, Jones DT, Witt
H, Lambert S, Albrecht S, Witt O, Vezina C, Shirinian M, Faury D,
et al: Genetic aberrations leading to MAPK pathway activation
mediate oncogene-induced senescence in sporadic pilocytic
astrocytomas. Clin Cancer Res. 17:4650–4660. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hu S, Chen R, Man X, Feng X, Cen J, Gu W,
He H, Li J, Chai Y and Chen Z: Function and expression of
insulin-like growth factor-binding protein 7 (IGFBP7) gene in
childhood acute myeloid leukemia. Pediatr Hematol Oncol.
28:279–287. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Laranjeira AB, de Vasconcellos JF, Sodek
L, Spago MC, Fornazim MC, Tone LG, Brandalise SR, Nowill AE and
Yunes JA: IGFBP7 participates in the reciprocal interaction between
acute lymphoblastic leukemia and BM stromal cells and in leukemia
resistance to asparaginase. Leukemia. 26:1001–1011. 2012.
View Article : Google Scholar
|
|
33
|
Heesch S, Bartram I, Neumann M, Reins J,
Mossner M, Schlee C, Stroux A, Haferlach T, Goekbuget N, Hoelzer D,
et al: Expression of IGFBP7 in acute leukemia is regulated by DNA
methylation. Cancer Sci. 102:253–259. 2011. View Article : Google Scholar
|
|
34
|
Tomanek B, Iqbal U, Blasiak B, Abulrob A,
Albaghdadi H, Matyas JR, Ponjevic D and Sutherland GR: Evaluation
of brain tumor vessels specific contrast agents for glioblastoma
imaging. Neuro Oncol. 14:53–63. 2012. View Article : Google Scholar :
|
|
35
|
Iqbal U, Albaghdadi H, Luo Y, Arbabi M,
Desvaux C, Veres T, Stanimirovic D and Abulrob A: Molecular imaging
of glioblastoma multiforme using anti-insulin-like growth
factor-binding protein-7 single-domain antibodies. Br J Cancer.
103:1606–1616. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Abu-Safieh L, Abboud EB, Alkuraya H,
Shamseldin H, Al-Enzi S, Al-Abdi L, Hashem M, Colak D, Jarallah A,
Ahmad H, et al: Mutation of IGFBP7 causes upregulation of
BRAF/MEK/ERK pathway and familial retinal arterial macroaneurysms.
Am J Hum Genet. 89:313–319. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shersher DD, Vercillo MS, Fhied C, Basu S,
Rouhi O, Mahon B, Coon JS, Warren WH, Faber LP, Hong E, et al:
Biomarkers of the insulin-like growth factor pathway predict
progression and outcome in lung cancer. Ann Thorac Surg.
92:1805–1811. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Georges RB, Adwan H, Hamdi H, Hielscher T,
Linnemann U and Berger MR: The insulin-like growth factor binding
proteins 3 and 7 are associated with colorectal cancer and liver
metastasis. Cancer Biol Ther. 12:69–79. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chen D, Yoo BK, Santhekadur PK, Gredler R,
Bhutia SK, Das SK, Fuller C, Su ZZ, Fisher PB and Sarkar D:
Insulin-like growth factor-binding protein-7 functions as a
potential tumor suppressor in hepatocellular carcinoma. Clin Cancer
Res. 17:6693–6701. 2011. View Article : Google Scholar : PubMed/NCBI
|
